Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

NCT02862106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

BIOLOGICAL: εPA-44

Sponsor

Chongqing Jiachen Biotechnology Ltd.

Collaborators

[object Object]